Entity Common Stock, Shares Outstanding of TG THERAPEUTICS, INC. from 09 Aug 2011 to 25 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
TG THERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Aug 2011 to 25 Feb 2026.
  • TG THERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 25 Feb 2026 was 159,688,256, a 1.7% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 159,688,256 +2,617,681 +1.7% 25 Feb 2026 10-K 27 Feb 2026 2025 FY
Q3 2025 158,759,451 +3,094,117 +2% 31 Oct 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 158,665,613 +3,842,476 +2.5% 05 Aug 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 157,070,575 +2,527,630 +1.6% 25 Feb 2025 10-K 03 Mar 2025 2024 FY
Q3 2024 155,665,334 +4,255,261 +2.8% 04 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 154,823,137 +3,845,573 +2.5% 05 Aug 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 154,542,945 +5,146,907 +3.4% 02 May 2024 10-Q 06 May 2024 2024 Q1
Q3 2023 151,410,073 +6,068,106 +4.2% 01 Nov 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 150,977,564 +5,703,516 +3.9% 02 Aug 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 149,396,038 +4,960,669 +3.4% 02 May 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 145,341,967 +2,398,828 +1.7% 04 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 145,274,048 +2,442,065 +1.7% 02 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 144,435,369 +2,967,012 +2.1% 06 May 2022 10-Q 10 May 2022 2022 Q1
Q3 2021 142,943,139 +11,452,944 +8.7% 03 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 142,831,983 +16,182,778 +13% 30 Jul 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 141,468,357 +27,720,371 +24% 04 May 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 131,490,195 +31,928,761 +32% 04 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 126,649,205 +31,894,054 +34% 05 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 113,747,986 +22,912,657 +25% 07 May 2020 10-Q 11 May 2020 2020 Q1
Q3 2019 99,561,434 +16,664,161 +20% 05 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 94,755,151 +11,936,543 +14% 02 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 90,835,329 +15,255,544 +20% 03 May 2019 10-Q 10 May 2019 2019 Q1
Q3 2018 82,897,273 +12,245,006 +17% 05 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 82,818,608 +13,982,715 +20% 03 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 75,579,785 +18,671,241 +33% 01 Mar 2018 10-K 15 Mar 2018 2017 FY
Q3 2017 70,652,267 +15,921,158 +29% 01 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 68,835,893 +14,379,270 +26% 01 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 56,908,544 +2,813,434 +5.2% 01 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 54,731,109 +2,211,423 +4.2% 01 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 54,456,623 +1,909,337 +3.6% 01 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 54,095,110 +7,551,178 +16% 01 Mar 2016 10-K 15 Mar 2016 2015 FY
Q3 2015 52,519,686 +8,555,336 +19% 06 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 52,547,286 +14,426,631 +38% 04 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 46,543,932 +12,170,007 +35% 12 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 43,964,350 +10,465,490 +31% 13 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 38,120,655 +4,843,715 +15% 21 Jul 2014 10-Q 24 Jul 2014 2014 Q2
Q1 2014 34,373,925 +8,553,187 +33% 01 Mar 2014 10-K 07 Mar 2014 2013 FY
Q3 2013 33,498,860 +8,439,865 +34% 01 Nov 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 33,276,940 +15,222,945 +84% 29 Jul 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 25,820,738 -258,863,239 -91% 01 Mar 2013 10-K 21 Mar 2013 2012 FY
Q3 2012 25,058,995 +17,660,679 +239% 12 Nov 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 18,053,995 +15,458,129 +595% 02 Aug 2012 10-Q/A 07 Sep 2012 2012 Q2
Q1 2012 284,683,977 01 Mar 2012 10-K 14 Mar 2012 2011 FY
Q3 2011 7,398,316 02 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 2,595,866 09 Aug 2011 10-Q/A 14 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.